 | • レポートコード：C9J09726 • 出版社/出版日：Prof Research / 2019年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール（受注後2-3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥450,000 (USD3,000) | ▷ お問い合わせ |
| Site License | ￥570,000 (USD3,800) | ▷ お問い合わせ |
| Global Site License | ￥750,000 (USD5,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 世界及び中国における非アルコール性脂肪肝疾患（NAFLD）薬市場について調査・分析したレポートで、非アルコール性脂肪肝疾患（NAFLD）薬の世界市場動向、市場規模、主要企業情報などが含まれています。非アルコール性脂肪肝疾患（NAFLD）薬の種類別・用途別に分けて分析し、地域別には、アメリカ、ヨーロッパ、日本、中国などに区分してまとめてあります。 ・非アルコール性脂肪肝疾患（NAFLD）薬産業の概要 ・非アルコール性脂肪肝疾患（NAFLD）薬の製造技術分析 ・主要企業分析：企業概要、製品情報、連絡先など ・世界及び中国の非アルコール性脂肪肝疾患（NAFLD）薬市場 2014年-2019年 ・世界及び中国の非アルコール性脂肪肝疾患（NAFLD）薬市場現状 ・企業別分析：Conatus Pharmaceuticals, Daewoong Pharmaceutical, Galmed International, Kyorin Pharmaceutical, Metabolic Solutions Development, Novartis AG, Phenex Pharmaceuticals, Raptor Pharmaceuticals, TCM Biotechなど ・地域別分析：アメリカ、ヨーロッパ、日本、中国など ・種類別分析、用途別分析 ・世界及び中国の非アルコール性脂肪肝疾患（NAFLD）薬市場予測 2019年-2024年 ・非アルコール性脂肪肝疾患（NAFLD）薬の産業チェーン分析 ・世界及び中国のマクロ経済動向と影響 ・世界及び中国の非アルコール性脂肪肝疾患（NAFLD）薬市場動向・課題・機会 ・新規プロジェクトへの提言・結論 |
Non-alcoholic Fatty Liver Disease (NAFLD) Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Non-alcoholic Fatty Liver Disease (NAFLD) Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Non-alcoholic Fatty Liver Disease (NAFLD) Drug manufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Overall, the report provides an in-depth insight of 2014-2024 global and Chinese Non-alcoholic Fatty Liver Disease (NAFLD) Drug market covering all important parameters.
The key ponits of the report:
1.The report provides a basic overview of the industry including its definition, applications and manufacturing technology.
2.The report explores the international and Chinese major industry players in detail. In this part, the report presents the company profile, product specifications, capacity, production value, and 2014-2019 market shares for each company.
3.Through the statistical analysis, the report depicts the global and Chinese total market of Non-alcoholic Fatty Liver Disease (NAFLD) Drug industry including capacity, production, production value, cost/profit, supply/demand and Chinese import/export.
4.The total market is further divided by company, by country, and by application/type for the competitive landscape analysis.
5.The report then estimates 2019-2024 market development trends of Non-alcoholic Fatty Liver Disease (NAFLD) Drug industry. Analysis of upstream raw materials, downstream demand, and current market dynamics is also carried out.
6.The report makes some important proposals for a new project of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry before evaluating its feasibility.
There are 3 key segments covered in this report: competitor segment, product type segment, end use/application segment.
For competitor segment, the report includes global key players of Non-alcoholic Fatty Liver Disease (NAFLD) Drug as well as some small players. At least 9 companies are included:
* Conatus Pharmaceuticals
* Daewoong Pharmaceutical
* Galmed International
* Kyorin Pharmaceutical
* Metabolic Solutions Development
* Novartis AG
For complete companies list, please ask for sample pages.
The information for each competitor includes:
* Company Profile
* Main Business Information
* SWOT Analysis
* Sales, Revenue, Price and Gross Margin
* Market Share
For product type segment, this report listed main product type of Non-alcoholic Fatty Liver Disease (NAFLD) Drug market in gloabal and china.
* Product Type I
* Product Type II
* Product Type III
For end use/application segment, this report focuses on the status and outlook for key applications. End users sre also listed.
* Application I
* Application II
* Application III
Reasons to Purchase this Report:
* Estimates 2019-2024 Non-alcoholic Fatty Liver Disease (NAFLD) Drug market development trends with the recent trends and SWOT analysis
* Market dynamics scenario, along with growth opportunities of the market in the years to come
* Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
* Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
* Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
* Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
* Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
* 1-year analyst support, along with the data support in excel format.
Any special requirements about this report, please let us know and we can provide custom report.
レポート目次Chapter One Introduction of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry
1.1 Brief Introduction of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
1.2 Development of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry
1.3 Status of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry
Chapter Two Manufacturing Technology of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
2.1 Development of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturing Technology
2.2 Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturing Technology
2.3 Trends of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturing Technology
Chapter Three Analysis of Global Key Manufacturers
3.1 Conatus Pharmaceuticals
3.1.1 Company Profile
3.1.2 Product Information
3.1.3 2014-2019 Production Information
3.1.4 Contact Information
3.2 Daewoong Pharmaceutical
3.2.1 Company Profile
3.2.2 Product Information
3.2.3 2014-2019 Production Information
3.2.4 Contact Information
3.3 Galmed International
3.2.1 Company Profile
3.3.2 Product Information
3.3.3 2014-2019 Production Information
3.3.4 Contact Information
3.4 Kyorin Pharmaceutical
3.4.1 Company Profile
3.4.2 Product Information
3.4.3 2014-2019 Production Information
3.4.4 Contact Information
3.5 Metabolic Solutions Development
3.5.1 Company Profile
3.5.2 Product Information
3.5.3 2014-2019 Production Information
3.5.4 Contact Information
3.6 Novartis AG
3.6.1 Company Profile
3.6.2 Product Information
3.5.3 2014-2019 Production Information
3.6.4 Contact Information
3.7 Phenex Pharmaceuticals
3.7.1 Company Profile
3.7.2 Product Information
3.7.3 2014-2019 Production Information
3.7.4 Contact Information
3.8 Company H
3.8.1 Company Profile
3.8.2 Product Information
3.8.3 2014-2019 Production Information
3.8.4 Contact Information
……
……
Chapter Four 2014-2019 Global and Chinese Market of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
4.1 2014-2019 Global Capacity, Production and Production Value of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry
4.2 2014-2019 Global Cost and Profit of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry
4.3 Market Comparison of Global and Chinese Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry
4.4 2014-2019 Global and Chinese Supply and Consumption of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
4.5 2014-2019 Chinese Import and Export of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Chapter Five Market Status of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry
5.1 Market Competition of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry by Company
5.2 Market Competition of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry by Country (USA, EU, Japan, Chinese etc.)
5.3 Market Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption by Application/Type
Chapter Six 2019-2024 Market Forecast of Global and Chinese Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry
6.1 2019-2024 Global and Chinese Capacity, Production, and Production Value of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
6.2 2019-2024 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry Cost and Profit Estimation
6.3 2019-2024 Global and Chinese Market Share of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
6.4 2019-2024 Global and Chinese Supply and Consumption of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
6.5 2019-2024 Chinese Import and Export of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Chapter Seven Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry Chain
7.1 Industry Chain Structure
7.2 Upstream Raw Materials
7.3 Downstream Industry
Chapter Eight Global and Chinese Economic Impact on Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry
8.1 Global and Chinese Macroeconomic Environment Analysis
8.1.1 Global Macroeconomic Analysis
8.1.2 Chinese Macroeconomic Analysis
8.2 Global and Chinese Macroeconomic Environment Development Trend
8.2.1 Global Macroeconomic Outlook
8.2.2 Chinese Macroeconomic Outlook
8.3 Effects to Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry
Chapter Nine Market Dynamics of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry
9.1 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry News
9.2 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry Development Challenges
9.3 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry Development Opportunities
Chapter Ten Proposals for New Project
10.1 Market Entry Strategies
10.2 Countermeasures of Economic Impact
10.3 Marketing Channels
10.4 Feasibility Studies of New Project Investment
Chapter Eleven Research Conclusions of Global and Chinese Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry
Tables and Figures
Figure Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Picture
Table Development of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturing Technology
Figure Manufacturing Process of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Table Trends of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturing Technology
Figure Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product and Specifications
Table 2014-2019 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity Production and Growth Rate
Figure 2014-2019 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Global Market Share
Figure Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product and Specifications
Table 2014-2019 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity Production and Growth Rate
Figure 2014-2019 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Global Market Share
Figure Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product and Specifications
Table 2014-2019 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity Production and Growth Rate
Figure 2014-2019 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Global Market Share
Figure Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product and Specifications
Table 2014-2019 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity Production and Growth Rate
Figure 2014-2019 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Global Market Share
Figure Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product and Specifications
Table 2014-2019 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Capacity Production Price Cost Production Value List
Figure 2014-2019 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity Production and Growth Rate
Figure 2014-2019 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Global Market Share
Figure Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product and Specifications
Table 2014-2019 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity Production and Growth Rate
Figure 2014-2019 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Global Market Share
Figure Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product and Specifications
Table 2014-2019 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity Production and Growth Rate
Figure 2014-2019 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Global Market Share
Figure Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product and Specifications
Table 2014-2019 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Product Capacity, Production, and Production Value etc. List
Figure 2014-2019 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity Production and Growth Rate
Figure 2014-2019 Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Global Market Share
……
……
Table 2014-2019 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity List
Table 2014-2019 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Manufacturers Capacity Share List
Figure 2014-2019 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturers Capacity Share
Table 2014-2019 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Manufacturers Production List
Table 2014-2019 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Manufacturers Production Share List
Figure 2014-2019 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturers Production Share
Figure 2014-2019 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity Production and Growth Rate
Table 2014-2019 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Manufacturers Production Value List
Figure 2014-2019 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Value and Growth Rate
Table 2014-2019 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Manufacturers Production Value Share List
Figure 2014-2019 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Manufacturers Production Value Share
Table 2014-2019 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity Production Cost Profit and Gross Margin List
Figure 2014-2019 Chinese Share of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production
Table 2014-2019 Global Supply and Consumption of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Table 2014-2019 Import and Export of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure 2018 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Manufacturers Capacity Market Share
Figure 2018 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Manufacturers Production Market Share
Figure 2018 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Manufacturers Production Value Market Share
Table 2014-2019 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Countries Capacity List
Figure 2014-2019 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Countries Capacity
Table 2014-2019 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Countries Capacity Share List
Figure 2014-2019 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Countries Capacity Share
Table 2014-2019 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Countries Production List
Figure 2014-2019 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Countries Production
Table 2014-2019 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Countries Production Share List
Figure 2014-2019 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Countries Production Share
Table 2014-2019 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Countries Consumption Volume List
Figure 2014-2019 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Countries Consumption Volume
Table 2014-2019 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Countries Consumption Volume Share List
Figure 2014-2019 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Key Countries Consumption Volume Share
Figure 78 2014-2019 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume Market by Application
Table 89 2014-2019 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume Market Share List by Application
Figure 79 2014-2019 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume Market Share by Application
Table 90 2014-2019 Chinese Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume Market List by Application
Figure 80 2014-2019 Chinese Non-alcoholic Fatty Liver Disease (NAFLD) Drug Consumption Volume Market by Application
Figure 2019-2024 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity Production and Growth Rate
Figure 2019-2024 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production Value and Growth Rate
Table 2019-2024 Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Capacity Production Cost Profit and Gross Margin List
Figure 2019-2024 Chinese Share of Global Non-alcoholic Fatty Liver Disease (NAFLD) Drug Production
Table 2019-2024 Global Supply and Consumption of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Table 2019-2024 Import and Export of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Industry Chain Structure of Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry
Figure Production Cost Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Figure Downstream Analysis of Non-alcoholic Fatty Liver Disease (NAFLD) Drug
Table Growth of World output, 2014 – 2019, Annual Percentage Change
Figure Unemployment Rates in Selected Developed Countries, January 2014 – March 2018
Figure Nominal Effective Exchange Rate: Japan and Selected Emerging Economies, September 2014-March 2018
Figure 2014-2019 Chinese GDP and Growth Rates
Figure 2014-2019 Chinese CPI Changes
Figure 2014-2019 Chinese PMI Changes
Figure 2014-2019 Chinese Financial Revenue and Growth Rate
Figure 2014-2019 Chinese Total Fixed Asset Investment and Growth Rate
Figure 2019-2024 Chinese GDP and Growth Rates
Figure 2019-2024 Chinese CPI Changes
Table Economic Effects to Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry
Table Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry Development Challenges
Table Non-alcoholic Fatty Liver Disease (NAFLD) Drug Industry Development Opportunities
Figure Map of Chinese 33 Provinces and Administrative Regions
Table Selected Cities According to Industrial Orientation
Figure Chinese IPR Strategy
Table Brief Summary of Suggestions
Table New Non-alcoholic Fatty Liver Disease (NAFLD) Drugs Project Feasibility Study
非アルコール性脂肪性肝疾患市場：世界及び中国市場分析・予測（～2024年） Non Alcoholic Fatty Liver Disease Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Non Alcoholic Fatty Liver Disease industry with a focus on the Chinese market. The report provides key statistics on the market status of the No…- 脂肪肝疾患薬市場：世界及び中国の市場分析・予測（～2024年） Fatty Liver Disease Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Fatty Liver Disease Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Fatty Liver Disease …
- 脂肪肝治療市場：世界及び中国の市場分析・予測（～2024年） Fatty Liver Treatment Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Fatty Liver Treatment industry with a focus on the Chinese market. The report provides key statistics on the market status of the Fatty Liver Treatment manu…
- 非アルコール性脂肪性肝炎薬市場：世界及び中国の市場分析・予測（～2024年） Non-Alcoholic Steatohepatitis Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Non-Alcoholic Steatohepatitis Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the …
- 肝線維症治療薬市場：世界及び中国市場分析・予測（～2024年） Liver Fibrosis Drug Market Insights 2019, Global and Chinese Scenario is a professional and in-depth study on the current state of the global Liver Fibrosis Drug industry with a focus on the Chinese market. The report provides key statistics on the market status of the Liver Fibrosis Drug manufactur…